| Fun in the Sun, and Other Perils It's a peak time for accidents. Courses, websites and other resources offer protection tips beyond bug spray. online.wsj.com |
Arena Pharmaceuticals: The Next Multi-Billion Dollar Biotech? John Tucker submits: Long-suffering Arena Pharmaceutical (ARNA) shareholders are basking in the warm glow of vindication this week. After years of disappointing performance, the company’s share value has more than doubled since June 30. With its lead product candidate Lorcaserin widely dismissed as the least effective of the three obesity drugs currently in late stage development, Arena’s share price actually dropped the day it announced the results of its first successful phase 3 clinical trial. With the events of the last few weeks, Arena’s market capitalization now exceeds that of its competitors by a wide margin (Table 1), and the recent share price trajectory suggests that Arena could become a billion dollar company well in advance of an FDA decision on Lorcaserin. click to enlargeComplete Story » seekingalpha.com |
Goal Is More Flu Shots for Americans Health officials are gearing up to persuade more Americans to get vaccinated against the flu this fall, in the aftermath of last year's swine-flu pandemic. online.wsj.com |
ShangPharma offering up to $52.8 million in IPO [AP] - Clinical research company ShangPharma Corp. expects to raise between $46.4 million and $52.8 million in an initial public offering this week. us.rd.yahoo.com |
Female Condom Launches in DC - Video The MAC AIDS Fund, the DC Department of Health, the Female Health Company, Washington AIDS Partnership, and CVS/pharmacy Launch Innovative Partnership to Provide Access to Female Condoms in Washington, D.C. feedproxy.google.com |